Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

HIV

“I don’t have a problem saying I have AIDs,” says Hydeia Broadbent in a video made as a part of a campaign with Centers for Disease Control and Prevention (CDC), but she acknowledges that many others still live in fear of sharing their status due to ongoing stigma. Human Immunodeficiency Virus (HIV), which can lead to Acquired Immunodeficiency Syndrome (AIDS), is no longer the death sentence it was in the 1980s, provided that you receive timely, consistent treatment. Still, it’s a serious illness with complications that can be fatal. Here’s what you need to know about HIV, and the benefits…

Read More

Regular MedShadow readers are likely familiar with the idea of deprescribing—the process of reducing the number or dose of drugs a person is taking. MedShadow has written about the phenomenon before. But, while the idea of taking fewer medications is simple, the process of deprescribing while balancing risks versus benefits is complicated. Some medications have withdrawal symptoms, and tapering may take time. The Therapeutics Initiative at the University of British Columbia is hosting a series of webinars with healthcare professionals sharing real-life stories of their own patients whose medications they were able to reduce, and what happened when they did.…

Read More

Updated Jan 5, 2023 with new details on Paxlovid side effects. Two recently authorized antiviral drugs designed to protect against the most severe outcomes of COVID-19 may be game-changers during the ongoing pandemic. Those benefits may come at a cost, however. It’s crucial that you and your healthcare providers understand New COVID Antivirals’ potential side effects, so you use them as safely as possible. “Obviously, if you’ve got a serious case of COVID, you need to be treated,” despite the risk of side effects says Katherine Seley-Radtke, PhD, professor of chemistry and biochemistry at the University of Maryland, Baltimore County.…

Read More

A now world-wide outbreak of hepatitis ‘that began in fall 2021 among young children, sickening hundreds, continues nearly eight months later, as of May 2022. The medical community is searching for its cause.  Some researchers believe it may have been triggered by COVID-19 infections or by colds or other viruses. The challenge is that the term hepatitis denotes an inflammation of the liver, but in order to treat it, a doctor needs to know what caused that inflammation. That’s problematic, because a doctor must know the cause to treat it effectively. Here’s what you need to know about the many…

Read More

Shalamar suffered from chronic insomnia. She couldn’t fall asleep after her late-night shifts as a server at a New York City bar. To address the insomnia, she sought advice from a psychiatrist who prescribed pills and told her to take them both at night and in the morning. She thought it was odd that she would need to take a pill to help her sleep during the day, but her doctor said that is how the medicine worked. She followed the doctor’s recommendations, though. “It did help me to sleep. I slept like a rock,” she says.  What her doctor…

Read More

The incidence of depression and anxiety has surged among adults in the United States over the course of the COVID-19 pandemic, according to the Centers for Disease Control and Prevention (CDC). The CDC survey suggested that from 2019 to 2020, symptoms of anxiety disorders and depression have tripled and quadrupled, respectively. As you might expect, prescriptions for antidepressant and antianxiety drugs also have spiked, according to the telehealth platform iPrescribe. While many patients with severe or chronic depression or anxiety may need to continue using these medications long term, you may think that, given the return of opportunities for working…

Read More

Anxiety is a normal reaction to stress, but for some people, it can become overwhelming and debilitating. People with types of anxiety disorder feel apprehensive and uneasy, and it’s common for them to experience negative thoughts that make them more fearful. According to the National Institute of Mental Health (NIMH): More than 40 million American adults ages 18 and older have an anxiety disorder, and nearly one-third of adults will experience an anxiety disorder at some point in their life. Anxiety disorders frequently co-occur with depressive disorders or substance abuse. Most people with an anxiety disorder also have depression.  Most…

Read More